{"id":"tp-52963","type":"article-newspaper","title":"Spruce Biosciences Posts $24 Million Q3 Loss, $8.51 Per Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52963","datePublished":"2026-11-10T09:35:20.000Z","dateModified":"2026-11-10T09:35:20.000Z","language":"en","abstract":"Cash and cash equivalents rose to $87.7 million on Sept. 30, 2026, from $48.9 million at the end of 2025.","section":"Business","references":[]}